Effect of monoclonal antibody on corneal graft survival across major and minor histocompatibility mismatches.
Duguid
I G
IG
Transplantation Unit, Walter and Eliza Hall Institute, Royal Melbourne Hospital, Parkville, Australia.
Koulmanda
M
M
Mandel
T E
TE
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015704:CD4 Antigens / Q000276:immunology; D016827:CD8 Antigens / Q000276:immunology; D016039:Corneal Transplantation / Q000276:immunology*; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006085:Graft Survival / Q000276:immunology*; D006649:Histocompatibility Antigens / Q000276:immunology*; D006650:Histocompatibility Testing; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D051379:Mice; D008807:Mice, Inbred BALB C; D008808:Mice, Inbred CBA; D015778:Minor Histocompatibility Antigens / Q000276:immunology*; D013997:Time Factors; D014184:Transplantation, Homologous; D014185:Transplantation, Isogeneic
D000911:Antibodies, Monoclonal; D015704:CD4 Antigens; D016827:CD8 Antigens; D006649:Histocompatibility Antigens; D007166:Immunosuppressive Agents; D015778:Minor Histocompatibility Antigens